Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503841
Status:
TERMINATED
Last Update Posted:
2019-04-30
First Post:
2007-07-17
Brief Title:
Erlotinib in Treating Women Undergoing Surgery For Stage I Stage II or Stage III Breast Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Organization Data
Organization:
Barbara Ann Karmanos Cancer Institute
Class:
OTHER
Study ID:
CDR0000554965
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Elaina Gartner
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Barbara Ann Karmanos Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |